Pyrimidine nucleotide catabolism

General cleavage mechanism

The process of pyrimidine nucleotide degradation begins with preparing the molecule for the cleavage of the nitrogenous base itself. This preparatory stage follows mechanisms that are completely analogous to the pathways of purine nucleotide degradation.

First, there is a successive cleavage of phosphoric acid residues and the carbohydrate component — ribose. Only after a free pyrimidine base remains from the nucleotide do specialized enzyme systems come into play, whose task is to break down the cyclic pyrimidine structure into simple aliphatic compounds.

Cytosine and uracil catabolic pathway

Cytosine and uracil share a single metabolic pathway because cytosine is converted into uracil during catabolism. The breakdown of these bases occurs in several successive steps requiring water and reducing equivalents.

1. At the first stage, cytosine undergoes a deamination reaction: an ammonia molecule is cleaved off, resulting in the formation of uracil.
2. Next, uracil is reduced. With the help of the NADH coenzyme and a hydrogen proton, it is converted into dihydrouracil.
3. The next step is the hydrolytic ring opening. Upon addition of a water molecule, dihydrouracil is converted into $\beta$-ureidopropionate.
4. At the final stage, another reaction involving water takes place. $\beta$-ureidopropionate is cleaved with the release of carbon dioxide and ammonia. The main carbon skeleton that remains after this reaction is $\beta$-alanine.

Thymine catabolic pathway

Unlike cytosine and uracil, thymine has an additional methyl group in its structure, which leads to the formation of a different end product. However, the logic of the enzymatic reactions remains similar.

• At the initial stage, thymine undergoes reduction in the presence of NADH and a hydrogen proton. As a result of this reaction, an intermediate compound is formed — dihydrothymine.
• Then, enzyme systems degrade the structure of dihydrothymine. During the breakdown, molecules of carbon dioxide and ammonia are released, and the main end product becomes $\beta$-aminoisobutyrate.

Properties and final fate of end products

A key distinguishing feature of pyrimidine catabolism is the physicochemical nature of the resulting metabolites. Pyrimidine breakdown products are highly water-soluble, which makes their excretion and further utilization safe and efficient (by comparison, purine breakdown leads to the formation of poorly soluble uric acid).

Fate of $\beta$-alanine:

• This compound has immense physiological significance, constantly circulates in blood plasma, and is found in various tissues.
• In muscle tissue, $\beta$-alanine is a key building block for the synthesis of specialized muscle peptides: carnosine and anserine.
• Bacteria actively use $\beta$-alanine as a raw material for the synthesis of pantothenic acid, which, in turn, is an essential component of coenzyme A (CoA-SH).

Fate of $\beta$-aminoisobutyrate:

• Part of the generated $\beta$-aminoisobutyrate is simply excreted from the body in the urine.
• Another part is involved in energy metabolism: the compound undergoes a transamination reaction, turning into methylmalonyl semialdehyde. This intermediate metabolite is then transformed into Succinyl-CoA, which directly enters the tricarboxylic acid cycle (Krebs cycle) for further oxidation.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Mechanisms of phosphoric acid and ribose cleavage from nucleotides
• Enzymes of the cytosine deamination reaction
• The role of the NADH coenzyme in the reduction of pyrimidine rings
• Biochemical functions of carnosine and anserine in muscle tissue
• The transamination reaction during the conversion of beta-aminoisobutyrate

Other topics in the "Nucleotide Metabolism" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.